During the past decade, University of Massachusetts Memorial Medical Center conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 48 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 29 clinical trials were completed. i.e. 78.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Massachusetts Memorial Medical Center" #1 sponsor was "Gynecologic Oncology Group" with 36 trials, followed by "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "Celgene" with 10 trials sponsored, "National Cancer Institute (NCI)" with 10 trials sponsored and "University of Massachusetts, Worcester" with 10 trials sponsored. Other sponsors include 121 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Massachusetts Memorial Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 88 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator and "Cystic Fibrosis Foundation" with 4 trials as a collaborator. Other collaborators include 114 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "University of Massachusetts Memorial Medical Center" are "Ovarian Cancer" (20 trials), "Leukemia" (14 trials), "Primary Peritoneal Cavity Cancer" (13 trials), "Lymphoma" (10 trials) and "Lung Cancer" (8 trials). Many other conditions were trialed in "University of Massachusetts Memorial Medical Center" in a lesser frequency.

Most popular intervention types in "University of Massachusetts Memorial Medical Center" are "Drug" (149 trials), "Other" (33 trials), "Biological" (28 trials), "Device" (27 trials) and "Procedure" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "cisplatin" (17 trials), "paclitaxel" (17 trials), "doxorubicin hydrochloride" (15 trials) and "cyclophosphamide" (14 trials). Other intervention names were less common.

The vast majority of trials in "University of Massachusetts Memorial Medical Center" are 161 trials for "All" genders, 56 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 37 active trials in "University of Massachusetts Memorial Medical Center". 3 are not yet recruiting, 20 are recruiting, 12 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 150 completed trials in University of Massachusetts Memorial Medical Center, undefined suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in University of Massachusetts Memorial Medical Center, 13 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 26 trials that are defined as “Not Applicable".

University of Massachusetts Memorial Medical Center has several departments that took part in Clinical trials: "UMASS Memorial Cancer Center - University Campus" - 47 trials, "Simonds-Sinon Regional Cancer Center" - 29 trials, "University of Massachusetts - colon & rectal surgery" - 2 trials, "UMASS - Neurology" - 2 trials, "University of Massachusetts Memorial Health Center; Arthritis and Total Joint Center" - 2 trials, "University of Massachusetts Memorial Children's Medical Center" - 2 trials